SomaKit TOC 40 µg
In stock
Indication
This medicinal product is for diagnostic use only.
After radiolabelling with gallium (68Ga) chloride solution, the solution of gallium (68Ga) edotreotide obtained is indicated for positron emission tomography (PET) imaging of somatostatin receptor overexpression in adult patients with confirmed or suspected well-differentiated gastroenteropancreatic neuroendocrine tumours (GEP-NET) for localising primary tumours and their metastases.
Practical information about SomaKit TOC
The representative of the marketing authorisation holder for SomaKit TOC is Novartis Sverige AB, Tel. +46 8 732 32 00, distributed in the Nordic region by SAM Nordic.
Further information about this medicinal product can be obtained from SAM Nordic, Tel: +46 8 720 58 22, info@samnordic.se.